3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Endometrial Neoplasms
8
Uterine Cervical Neoplasms
6
Ovarian Neoplasms
4
Uterine Neoplasms
2
Leiomyoma
2
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
2
Carcinoma, Ovarian Epithelial
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Prolapse
1
Uterine Cervical Dysplasia
1
Sarcoma
1
Precancerous Conditions
1
Myofibroma
1
Menstruation Disturbances
1
Menorrhagia
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Fallopian Tube Neoplasms
1
Endometriosis
1
Endometrial Hyperplasia
1
Carcinoma, Squamous Cell
1
Carcinoma, Adenosquamous
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Colposcopy
5
Polymerase Chain Reaction
4
Biopsy
4
Watchful Waiting
2
Vaginal Smears
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Histological Techniques
2
Cidofovir
2
human papillomavirus vaccine, TA
1
human papillomavirus vaccine, L1 type 16, 18
1
Zoledronic Acid
1
Tretinoin
1
Transurethral Resection of Prostate
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Radiotherapy
1
Pregnancy Tests
1
Papanicolaou Test
1
Mindfulness-Based Stress Reduction
1
Microarray Analysis
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Gene Expression Profiling
1
Folic Acid
1
Fluorophotometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Hysterectomy
×
Gynecologic
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled